Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
723,871
-
Share change
-
+100,838
-
Total reported value
-
$72,761,996
-
Price per share
-
$100.56
-
Number of holders
-
5
-
Value change
-
+$10,136,623
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Novartis AG - COM as of Q2 2023
As of 30 Jun 2023,
Novartis AG - COM was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
723,871 shares.
The largest 5 holders included
Aristotle Capital Management, LLC, Boston Common Asset Management, LLC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, Cullen Capital Management, LLC, and KENNEDY CAPITAL MANAGEMENT LLC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.